Trials / Sponsors / Zhejiang Genfleet Therapeutics Co., Ltd.
Zhejiang Genfleet Therapeutics Co., Ltd.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC) Intermittent Claudication, Peripheral Artery Disease | Phase 2 | 2022-12-01 |
| Completed | A Phase I Study of GFH312 in Healthy Chinese Subjects Healthy Volunteer | Phase 1 | 2022-11-29 |
| Withdrawn | A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 / Phase 2 | 2022-04-01 |
| Completed | A Study of GFH018 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2019-08-30 |